Copertina

Use of immunomodulatory therapy as part of comprehensive treatment of non-severe community-acquired pneumonia and its long-term results

Background: This study investigates the efficiency of two different types of immunomodulators for the treatment of non-severe community-acquired pneumonia (CAP) and assesses their long-term effects. Methods: The study included 55 patients with non-severe CAP. Group 1 (control) received only standard...

Descrizione completa

Salvato in:

Dettagli Bibliografici
Autori principali:	Mikhail P Kostinov (Autore), Vilia V Gainitdinova (Autore), Svetlana V Kazharova (Autore), Anna E Vlasenko (Autore), Vflentina B Polishchuk (Autore), Kirill V Mashilov (Autore)
Natura:	Libro
Pubblicazione:	BioExcel Publishing Ltd, 2023-08-01T00:00:00Z.
Soggetti:	article
Accesso online:	Connect to this object online.
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Changes in nasal, pharyngeal and salivary secretory IgA levels in patients with COVID-19 and the possibility of correction of their secretion using combined intranasal and oral administration of a pharmaceutical containing antigens of opportunistic microorganisms
di: Mikhail Kostinov, et al.
Pubblicazione: (2023)

The Effectiveness of Immunomodulatory Therapy of Community-acquired Pneumonia in Frequently ill Children
di: T. G. Malanicheva, et al.
Pubblicazione: (2018)

Experience of Using Immunomodulatory Therapy in Comprehensive Treatment of Chronic Tonsillitis in Children
di: Yu.V. Marushko, et al.
Pubblicazione: (2015)

Features of the respiratory function in children with community-acquired pneumonia
di: D.V. Usenko
Pubblicazione: (2019)

Vaccination against pneumococcal infection in patients with chronic kidney disease
di: A. A. Tarasova, et al.
Pubblicazione: (2020)

Severe community-acquired pneumonia: principles of diagnostics and intensive therapy
di: V.I. Chernii
Pubblicazione: (2023)

Development of a model for the differential diagnosis of community-acquired bacterial pneumonia and viral lung injury in hospitalized adult patients
di: O. A. Kupriushina, et al.
Pubblicazione: (2024)

Antibacterial therapy of community-acquired pneumonia in children
di: A.E. Abaturov, et al.
Pubblicazione: (2018)

Retrospective pharmacoeconomic study of antibiotic therapy in community-acquired pneumonia
di: A. A. Taube, et al.
Pubblicazione: (2023)

Acquired long QT interval in athletes
di: A. S. Yunisova, et al.
Pubblicazione: (2022)

Analysis of antiviral use efficiency criteria in the complex pharmacotherapy of community acquired pneumonia
di: S. O. Soloviov, et al.
Pubblicazione: (2019)

Pharmacoeconomic research of pharmacotherapy schemes of community-acquired pneumonia with the inclusion of antiviral drugs
di: S. O. Soloviov, et al.
Pubblicazione: (2020)

Pneumonia acquired in the Community
di: María Caridad Fragoso Marchante, et al.
Pubblicazione: (2007)

Pneumonia acquired in the Community
di: María Caridad Fragoso Marchante, et al.
Pubblicazione: (2007)

Modern approaches at the management of children with community-acquired pneumonia
di: Aleksander A. Baranov, et al.
Pubblicazione: (2023)

A comprehensive approach to the treatment of septic pelvic inflammatory disease using immunomodulatory therapy
di: I A Lapina, et al.
Pubblicazione: (2016)

Antimicrobial therapy of community-acquired pneumonia in a hospital setting (clinical and economic aspects)
di: O. V. Zhukova, et al.
Pubblicazione: (2018)

Methods of visualization in the diagnosis of COVID‑19 community‑acquired pneumonia
di: М.І. Gumeniuk, et al.
Pubblicazione: (2020)

Non-invasive respiratory support in patients with severe community-acquired pneumonia
di: S. V. Korotchenko, et al.
Pubblicazione: (2023)

Use of medications in children hospitalized with community-acquired pneumonia
di: D. D. Siukaeva, et al.
Pubblicazione: (2018)

Investigational and Experimental Drugs for Community-Acquired Pneumonia: the Current Evidence
di: Sellarès-Nadal J, et al.
Pubblicazione: (2020)

Features of Asthenic Syndrome and Autonomic Disorders in Children with Community-Acquired Pneumonia
di: S.L. Niankovskyi, et al.
Pubblicazione: (2015)

Incidence of Antibiotic Treatment Failure in Patients with Nursing Home-Acquired Pneumonia and Community Acquired Pneumonia
di: Mariana Lopes, et al.
Pubblicazione: (2021)

The Role of the Essay-Test in Acquiring Reading and Reading Comprehension Skills
di: Zona V. Mrkalj, et al.
Pubblicazione: (2021)

Community-Acquired Pneumonia in Children
di: I.L. Vysochina, et al.
Pubblicazione: (2014)

THE RELATIONSHIP OF THIOL STATUS, AND COMPONENTS OF SIGNALING PATHWAYS THAT REGULATE INFLAMMATION IN CONVALESCENTS WITH COMMUNITY-ACQUIRED PNEUMONIA
di: S. S. Bondar, et al.
Pubblicazione: (2018)

MODERN MODEL FORMATION OF DRUG PROVISION OF PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA IN KABARDINO-BALKARIA
di: A. A. Umirova, et al.
Pubblicazione: (2019)

Long-Term Surgical Complications in the Oral Cancer Patient: a Comprehensive Review. Part I
di: Antonia Kolokythas
Pubblicazione: (2010)

Long-Term Surgical Complications in the Oral Cancer Patient: a Comprehensive Review. Part II
di: Antonia Kolokythas
Pubblicazione: (2010)

Diagnosis and antibacterial treatment for community-acquired pneumonia in children during the COVID-19 pandemic
di: S.V. Zaitseva, et al.
Pubblicazione: (2021)

Diagnosis and antibacterial treatment for community-acquired pneumonia in children during the COVID-19 pandemic
di: S.V. Zaitseva, et al.
Pubblicazione: (2021)

Comparative Analysis of Drug Interactions with Antibacterial Agents in the Treatment of Community-Acquired Pneumonia
di: A. A. Taube, et al.
Pubblicazione: (2021)

Analysis of the selection of antimicrobial drugs for community-acquired pneumonia by final year medical students
di: V. G. Deriushkin
Pubblicazione: (2021)

Evaluation of the Effect of Comorbidity on the Efficacy and Safety of β-Lactam Antibiotics in Patients with Community-Acquired Pneumonia
di: O. V. Muslimova, et al.
Pubblicazione: (2022)

Community-Acquired Pneumonia in Children: Current Approaches to the Duration of Antibiotic Therapy
di: S.O. Mokiia-Serbina, et al.
Pubblicazione: (2016)

Immunomodulatory Properties of Vitamin D in Children
di: L.V. Kvashnina
Pubblicazione: (2013)

EVALUATION OF RATIONALITY OF EXPENSES ON TREATMENT OF SEVERE COMMUNITY-ACQUIRES PNEUMONIA IN MULTI-PROFILE HOSPITAL
di: I. V. Demko, et al.
Pubblicazione: (2016)

Costs of pharmacotherapy in pediatric patients with community-acquired pneumonia: mathematical and statistical analysis
di: I. A. Narkevich, et al.
Pubblicazione: (2019)

The place of endogenous antimicrobial peptides in the pathogenetic mechanisms of the development of community-acquired pneumonia caused by Streptococcus pneumoniae among infants
di: G.O. Lezhenko, et al.
Pubblicazione: (2017)

Mucoactive therapy in community-acquired pneumonia
di: Andrey A. Zaytsev, et al.
Pubblicazione: (2023)